Skip to main content
Sartorius Stedim Biotech logo

Sartorius Stedim Biotech — Investor Relations & Filings

Ticker · DIM ISIN · FR0013154002 LEI · 52990006IVXY7GCSSR39 PA Manufacturing
Filings indexed 428 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country FR France
Listing PA DIM

About Sartorius Stedim Biotech

https://www.sartorius.com/en

Sartorius Stedim Biotech is a leading international provider of equipment and services for the biopharmaceutical industry. The company offers integrated solutions that support the entire lifecycle of drug development and manufacturing, from research and development to quality assurance and commercial production. Its comprehensive portfolio includes technologies for filtration, fluid management, fermentation, cell culture, and purification. Key products encompass bioreactors, single-use systems, process filtration equipment, cell culture media, and data analytics software. Sartorius Stedim Biotech enables its customers to develop and manufacture biotech medications, including cell and gene therapies, more efficiently and safely, helping to accelerate the translation of scientific discoveries into patient care.

Recent filings

Filing Released Lang Actions
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure under French AMF rules (Article L233-8-II and Article 223-6), declaring the total number of issued shares and voting rights of Sartorius Stedim Biotech SA at a given date. It is not an earnings release, financial statement, or proxy, nor does it report a change by itself (e.g., new issuance, repurchase). Instead, it serves as a general compliance announcement of share capital and voting rights and thus falls under the fallback category for miscellaneous regulatory filings. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-06-01 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a statutory declaration under French Commercial Code and AMF regulations detailing the total number of shares and theoretical/net voting rights at a specific date. This is not a full financial report or management discussion but a periodic voting rights announcement. It matches the “Declaration of Voting Results & Voting Rights Announcements” category (DVA).
2026-06-01 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Regulatory Filings Classification · 85% confidence The document is a formal French regulatory announcement disclosing the total number of shares and voting rights making up the issued capital as of a specific date, filed under AMF rules. It is not presenting financial results, board changes, votes, or detailing an actual share issuance event but rather serves as a compliance/ regulatory filing. Therefore it best fits the Generic Regulatory Filings category.
2026-06-01 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Major Shareholding Notification Classification · 100% confidence The document is a declaration related to the number of shares and voting rights making up the issued capital of Sartorius Stedim Biotech SA. It references specific articles of the Code of commerce and AMF regulations, indicating it is a formal notification about shareholding and voting rights. The content focuses on share counts and voting rights as of a specific date (April 30, 2026). This matches the definition of a Major Shareholding Notification, which involves notification of changes in significant share ownership levels or voting rights. The document is short and does not contain financial statements or other report types, so it is not an Annual Report or Interim Report. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2026-05-05 English
Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Major Shareholding Notification Classification · 95% confidence The document is a declaration related to the number of shares and voting rights composing the company's share capital, referencing specific legal articles (Article L 233-8-II of the French Commercial Code and article 223-6 of the AMF regulation). It provides data as of a specific date (April 30, 2026) about total shares and voting rights. This matches the description of a Major Shareholding Notification, which involves reporting changes or status of significant share ownership or voting rights. The document is short and focused solely on shareholding and voting rights data, not a full financial report or other types of filings.
2026-05-05 French
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Major Shareholding Notification Classification · 95% confidence The document is a declaration related to the number of shares and voting rights making up the issued capital of Sartorius Stedim Biotech SA. It references specific regulatory articles (Article L 233-8-II of the Code of commerce and article 223-6 of the AMF regulations) and provides detailed share capital and voting rights data as of April 30, 2026. The content is focused on shareholding structure and voting rights rather than financial performance, management changes, or other report types. This matches the definition of a Major Shareholding Notification (MRQ), which involves notifications of changes in significant share ownership or voting rights. The document is relatively short and is a direct declaration, not an announcement of a report publication or a certification. Therefore, the appropriate classification is MRQ with high confidence.
2026-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.